AcuityMDTranslation site

What is AcuityMD?

AcuityMD is a Boston, Massachusetts-based medical technology company that specializes in providingMedical equipmentindustry to provide data-driven commercialization solutions. Founded in 2018, the company is committed to helping medical device companies accurately identify market opportunities, optimize sales strategies, and accelerate the full lifecycle management of their products from R&D to post-launch through the integration of medical data and the construction of an intelligent platform.

AcuityMD's History

• 2018: AcuityMD is founded and begins developing a medical device data platform.
• May 2022: Closed $31 million in Series A funding led by Redpoint Ventures and followed by Benchmark, Ajax Health and Artisanal Ventures. Funds are being used to expand the business and develop the platform.
• June 2024: Closed $45 million in Series B funding led by ICONIQ Growth with participation from Atreides Management, StepStone Group and existing investors Redpoint Ventures, Benchmark Capital and Artisanal Ventures. Funds are being used to expand the business intelligence platform.
• April 2026: Closes $80 Million in Series C Financing, Valuing the Company at $955 Million and Accumulating Over $160 Million in Financing. The round was led by StepStone Group and followed by Benchmark, Redpoint Ventures, ICONIQ and Atreides Management. The funds were used to accelerateAI AgentCapabilities, deepening the medical technology ontology and expanding to the full product lifecycle.

AcuityMD's Products and Services

AcuityMD's core product is a medical device lifecycle data platform that serves medical device organizations through the following capabilities:

1. Market Opportunity Identification: Using big data and AI technology to analyze data such as physician procedure volume, product preferences, and care affiliate sites to help companies pinpoint their target markets.
2. Sales strategy optimization: Provide dynamic insights to monitor market dynamics and opportunities in real time, support personalized sales strategy development, and improve sales success rate.
3. Total Life Cycle Management: Covering the entire life cycle of a medical device, from market analysis at the R&D stage, simulation of pricing strategies before launch, to pharmacovigilance tracking after launch.
4. AI Agent System (AcuityAI): An AI assistant built specifically for medical technology sales scenarios, capable of autonomously completing information retrieval, logical reasoning and scenario generation to provide decision-making assistance.

AcuityMD's Core Technology

AcuityMD's core technology is its proprietary MedTech Ontology, a continuously enriched and dynamically updated knowledge graph. The map systematically maps physicians, providers, networks, procedures, reimbursement policies, and the complex relationships between them. For example, it not only knows which hospital a cardiologist practices at, but also the physician's areas of expertise, which peers he or she has referral collaborations with, recent changes in purchasing contracts at his or her hospital, and the reimbursement rates for his or her commonly used consumables in the latest Medicare catalog.

From there, AcuityMD aligns MedTech Ontology with each client's internal data, such as contract terms, product indications, sales territory segmentation, CRM activity records, etc., ultimately outputting a unified, real-time updated view of the healthcare market. This ontology-driven architecture allows AcuityMD to answer highly contextualized questions such as, “Which three surgeons in the Boston area should I prioritize visiting next month to maximize the likelihood of winning a contract for that newly launched joint replacement device?”.

The Future of AcuityMD

1. Growing market demandAcuityMD's data platform and AI solutions help organizations “see better, move faster” to meet market demands as the healthcare technology industry faces a wave of hospital mergers, value-based care models, and other challenges that require more accurate market insights and sales strategies.
2. Continuous technology iteration: As AI technology continues to evolve, AcuityMD's AI Agent capabilities will continue to grow to serve more roles (e.g., sales leaders, marketing teams, product managers, etc.) and provide more accurate decision-making assistance.
3. Total Life Cycle ManagementAcuityMD is evolving from sales enablement to full lifecycle management, and will cover R&D, clinical, registration, marketing, sales and other aspects, becoming the “operating system” of the medical technology industry and reshaping the way the industry collaborates.
4. Continued capital support: AcuityMD has received multiple rounds of financing, totaling more than $160 million and a valuation of $955 million. The continuous support of capital provides a strong guarantee for the company's development.